About Prolistem (Azoospermia Treatment)

ABOUT US

About Prolistem®

Prolistem® is the third generation of SpermHope® treatment, the new kit has improved formula and stronger effect to increase the success chances for non obstructive azoospermia patients.

Prolistem® is a trademark of Med-Hija LLC (DOS ID #:  4836543) (Patent #9,662,361).

Prolistem® is the outcome of extensive male fertility research, as well as animal model research. All of this research has led to development of the Prolistem® treatment, which is based on a better understanding of spermatogenesis.

Prolistem® is based on a new concept of testicular cells’ behavior that furthers the understanding of sperm production and the mechanisms of hormonal actions.

The risk of a potentially harmful drug interaction increases with each drug taken. On the contrary, the Prolistem® formula is an all-natural supplement to renew testicular cells’ division. Our research results show a significant increase in the recovery of testicular cell division and sperm production.

 “ Prolistem® is designed to enhance the fertility of men with non-obstructive azoospermia.”

About Founder

About Dr. Abuelhija
Dr Abuelhija

Dr. Abuelhija is a scientist in reproductive biology. As a PhD. in the male fertility field for long time has given me the opportunity to think in new directions and change the idea that non-obstructive azoospermia is untreatable.

The old theories about sperm production are changing all the time since we do not fully understand the testis mechanism. Unfortunately, many urologists still believe in the old theories that have been proven false.

Dr. Abuelhija has been involved in male fertility studies since 2004, starting with the effect of cytokines and growth factors on the spermatogenesis in mice and humans,
as well as in vitro cultures of germ cells and the effects of radiation on spermatogenesis recovery in rats.

Dr. Abuelhija is the author and co-author of more than 15 scientific articles, abstracts, and book chapters and specializes in non-obstructive azoospermia and in helping men to increase their chances to restore their fertility.

EDUCATION

2012

Postdoctoral Fellowship in Reproductive Toxicology and Endocrinology, MD Anderson Cancer Center, Houston, Texas, USA.

2009

Doctor of Philosophy (PhD) in Microbiology and Immunology, Ben-Gurion University, Beer-Sheva, Israel.

2006

Master Degree (MSc) in Microbiology and Immunology , Ben-Gurion University, Beer-Sheva, Israel.

2003

Bachelor of Medical Laboratory Science (BMLSc), Ben-Gurion University, Beer-Sheva, Israel.

AWARDS

2011

National Institutes of Health Travel Award, American Society of Andrology Conference in Montreal, Quebec, Canada. 2009

2007-2009

Grant of the Planning and Budgeting Committee, The Israeli Council for Higher Education for Excellence Ph.D. Student

2008

Ben-Gurion University Award, The Faculty of Health Sciences for Excellence Ph.D. Student in memory of Yaakov Tal

2006

Ben-Gurion University Rector Award, for Excellence M.S.